Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Download PDF
Dtsch Med Wochenschr 2008; 133(14): 720
DOI: 10.1055/s-2008-1067314
DOI: 10.1055/s-2008-1067314
Pro & Contra | Commentary
Pneumologie© Georg Thieme Verlag KG Stuttgart · New York
Die Therapie der pulmonal-arteriellen Hypertonie bei COPD ist sinnvoll - pro
The treatment of pulmonary arterial hypertension associated with chronic obstructive pulmonary disease makes sense - proFurther Information
Publication History
Publication Date:
25 March 2008 (online)
Schlüsselwörter
pulmonal-arterielle Hypertonie - COPD - Endothelin-Antagonisten - Prostacyclin-Analoga - Phosphodiesterase-Inhibitoren
Key words
pulmonary hypertension - COPD - endothelin antagonists - prostacyclin analogues - phosphodiesterase inhibitors
Literatur
- 1
Alp S, Skrygan M, Schmidt W E, Bastian A.
Sildenafil improves hemodynamic parameters in COPD-an investigation of six patients.
Pulm Pharmacol Ther.
2006;
19
386-390
MissingFormLabel
- 2
Ghofrani H A, Voswinckel R, Reichenberger F. et al .
Hypoxia- and non-hypoxia-related pulmonary hypertension - established and new therapies.
Cardiovasc Res.
2006;
72
30-40
MissingFormLabel
- 3
MacNee W.
Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two.
Am J Respir Crit Care Med.
1994;
150
1158-1168
MissingFormLabel
- 4
Santos S, Peinado V I, Ramirez J. et al .
Characterization of pulmonary vascular remodelling in smokers and patients with mild
COPD.
Eur Respir J.
2002;
19
632-638
MissingFormLabel
Prof. Dr. Hossein-Ardeschir Ghofrani
Medizinische Klinik II/V, Universitätsklinikum Gießen und Marburg GmbH
Klinikstraße 36
35392 Gießen
Email: ardeschir.ghofrani@innere.med.uni-giessen.de